Hi Ted- looks like a busted IPO
NeuroSense shares open at $4.55, IPO priced at $6.00 per unit 12/09/21 NRSN NeuroSense Therapeutics priced its initial public offering of 2M units, each consisting of one ordinary share and a warrant representing the right to purchase one ordinary share with an exercise price of $6.00 per share, at an initial public offering price of $6.00 per unit. NeuroSense's ordinary shares and warrants are trading on the Nasdaq Capital Market under the ticker symbols "NRSN" and "NRSNW," respectively.
NeuroSense initiated with a Buy at Maxim 01/07 NRSN Maxim analyst Naz Rahman initiated coverage of NeuroSense with a Buy rating and $7.00 price target. T
he company's lead asset PrimeC, which is being developed to treat amyotrophic lateral sclerosis, demonstrated positive results in a pre-clinical Zebrafish model in which it increased fish swim distance and velocity, the analyst tells investors in a research note. Rahman adds that he is positive on PrimeC's mechanism of action and potential as an approved therapy for indications that current treatments do not address.

Any bio that only needs to increase swim distance in Zebra fish has a low bar to hurdle!
If i worked at this company I would of sprinkled in some protein powder into the fish tank and energy boosting herbs when no one was looking.
vol outrageous I don't get it... feakin' Zebra fish....
Vol 105,MILLION
Avg. Volume 610,845
I would stay far away. This will be $4.00 soon which seems the fair price.
6.79+5.23(+335.26%)
As of 12:13PM EDT.